Article

Low CCL19 Expression Is Associated With Adverse Clinical Outcomes For Patients With Advanced Stage Follicular Lymphoma

2021-08-06

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> This study aimed to explore the interactions and relationships of genes and recognize the hub genes associated with prognosis in follicular lymphoma (FL) treated with first-line rituximab combined with chemotherapy.<bold>Method: </bold>RNA sequencing data of dataset GSE65135 (n=24) were included in differentially expressed genes (DEGs) analysis. Weighted gene co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 57988be0-ec2f-5e8d-b591-1f71f0b62d00
DOI: 10.21203/rs.3.rs-764209/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Low CCL19 Expression Is Associated With Adverse Clinical Outcomes For Patients With Advanced Stage Follicular LymphomaDOI 10.21203/rs.3.rs-764209/v1Read

Low CCL19 Expression is Associated With Adverse Clinical Outcomes For Follicular Lymphoma Patients Treated With ChemoimmunotherapySemantic proximity Read

Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysisSemantic proximity Read

The Expression and Prognostic Value of CCL19 in Breast CancerSemantic proximity Read

Identification of prognosis-related genes in Burkitt Lymphoma by integrated bioinformatic analysis.Semantic proximity Read

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapySemantic proximity Read

Identification of the driving mechanisms associated with aggressive transformation and prognosis in follicular lymphomasSemantic proximity Read

Clinical features and prognosis analysis of patients with follicular lymphoma: A real-world study in ChinaSemantic proximity Read

Decreased Expression of T-Cell-Associated Immune Markers Predicts Poor Prognosis in Patients with Advanced Follicular Lymphoma Received Rituximab Plus BendamustineSemantic proximity Read

CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironmentSemantic proximity Read

Hepatitis B Virus-Associated Follicular Lymphoma Reveals T-Cell Inflamed Phenotype and Response to LenalidomideSemantic proximity Read

Exploring The Molecular Mechanisms of Classical Hodgkin Lymphoma Through Bioinformatics AnalysisSemantic proximity Read

Immunogenomic-based analysis of hierarchical clustering of diffuse large cell lymphomaSemantic proximity Read